Mutual of America Capital Management’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36M | Sell |
209,363
-7,317
| -3% | -$82.5K | 0.03% | 762 |
|
|
2025
Q1 | $2.19M | Sell |
216,680
-142,139
| -40% | -$1.43M | 0.03% | 797 |
|
|
2024
Q4 | $4.24M | Sell |
358,819
-9,047
| -2% | -$107K | 0.05% | 536 |
|
|
2024
Q3 | $4.25M | Buy |
367,866
+40,787
| +12% | +$471K | 0.04% | 552 |
|
|
2024
Q2 | $3.46M | Buy |
327,079
+1,142
| +0.4% | +$12.1K | 0.04% | 641 |
|
|
2024
Q1 | $3.44M | Buy |
325,937
+175,574
| +117% | +$1.85M | 0.04% | 663 |
|
|
2023
Q4 | $1.69M | Buy |
150,363
+28,504
| +23% | +$320K | 0.02% | 962 |
|
|
2023
Q3 | $1.42M | Sell |
121,859
-5,009
| -4% | -$58.5K | 0.02% | 980 |
|
|
2023
Q2 | $1.28M | Buy |
+126,868
| New | +$1.28M | 0.01% | 1018 |
|